Theme V – Efficacy and Safety Testing of Drugs and Biologicals
Coordinators
M. Belen Tornesi, AbbVie, North Chicago,IL, USA – IQ consortium
Tobias Schnitzer, Roche Diagnostics GmbH; Penzberg, Germany – IQ consortium
V-1 Pathways based assays in drug development
Humberto Pinheiro de Araujo, INCQS/FIOCRUZ, Brazil
M. Belen Tornesi, AbbVie, USA – IQ consortium
V-2 Disease models in vivo
Nicolas Dudoignon, Sanofi R&D, France
Tobias Schnitzer, Roche Diagnostics, Germany – IQ consortium
V-3a Potency testing of human and veterinary vaccines
Jean-Michel Chapsal, Sanofi-Pasteur, France
Coenraad Hendriksen, Utrecht University, The Netherlands
V-3b Potency testing of human and veterinary vaccines
Lukas Bruckner, Institute of Virology and Immunology, Switzerland
Wlamir Correa de Moura, INCQS/FIOCRUZ, Brazil
V-4 Medical devices and Biologicals
Tobias Schnitzer, Roche Diagnostics, Germany – IQ consortium
Gianni Dal Negro, GlaxoSmithKline, UK – IQ consortium
